FMS – Fresenius Medical Care AG ADR
FMS — Price & Forward EBITDA
Forward EBITDA (M)
Float Short %
0.33
Margin Of Safety %
10
Put/Call OI Ratio
1.12
EPS Next Q Diff
-0.31
EPS Last/This Y
0.57
EPS This/Next Y
0.93
Price
22.07
Target Price
25.59
Analyst Recom
2.95
Performance Q
-8.27
Upside
91.5%
Beta
0.87
Ticker: FMS
15 items
«
‹
of 1
›
»
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2026-02-27 | FMS | 23.47 | 0.76 | 999.99 | 3977 |
| 2026-03-03 | FMS | 23.36 | 0.76 | 0.50 | 3978 |
| 2026-03-04 | FMS | 23.03 | 0.76 | 3.00 | 3981 |
| 2026-03-06 | FMS | 22.97 | 0.76 | 999.99 | 3986 |
| 2026-03-09 | FMS | 23.42 | 0.76 | 999.99 | 3986 |
| 2026-03-10 | FMS | 22.97 | 0.76 | 999.99 | 3986 |
| 2026-03-11 | FMS | 22.74 | 0.83 | 0.00 | 4130 |
| 2026-03-12 | FMS | 22.76 | 0.83 | 0.00 | 4130 |
| 2026-03-13 | FMS | 22.75 | 0.83 | 0.00 | 4130 |
| 2026-03-17 | FMS | 23.16 | 0.85 | 0.00 | 4079 |
| 2026-03-18 | FMS | 22.4 | 0.85 | 0.00 | 4079 |
| 2026-03-20 | FMS | 21.65 | 0.84 | 0.03 | 4110 |
| 2026-03-25 | FMS | 22.26 | 1.12 | 999.99 | 3213 |
| 2026-03-26 | FMS | 22.37 | 1.12 | 0.00 | 3214 |
| 2026-03-27 | FMS | 22.07 | 1.12 | 999.99 | 3217 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
15 items
«
‹
Current Page1 of 1
›
»
20 items
«
‹
of 1
›
»
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2026-02-27 | FMS | 23.47 | 22.4 | 587.6 | 2.62 |
| 2026-03-02 | FMS | 23.47 | 24.3 | 653.0 | 2.56 |
| 2026-03-03 | FMS | 23.37 | 24.3 | 648.9 | 2.56 |
| 2026-03-04 | FMS | 23.02 | 24.3 | 635.4 | 2.56 |
| 2026-03-05 | FMS | 23.05 | 24.3 | 667.5 | 2.56 |
| 2026-03-06 | FMS | 22.96 | 24.3 | 659.9 | 2.56 |
| 2026-03-09 | FMS | 23.43 | 18.9 | 675.1 | 2.56 |
| 2026-03-10 | FMS | 22.98 | 18.9 | 619.6 | 2.56 |
| 2026-03-11 | FMS | 22.73 | 18.9 | 609.8 | 2.56 |
| 2026-03-12 | FMS | 22.74 | 18.9 | 624.3 | 2.55 |
| 2026-03-13 | FMS | 22.78 | 18.9 | -85.5 | 2.55 |
| 2026-03-17 | FMS | 23.15 | 18.9 | -77.7 | 2.55 |
| 2026-03-18 | FMS | 22.40 | 18.9 | -134.1 | 2.55 |
| 2026-03-19 | FMS | 22.12 | 18.9 | -114.9 | 2.55 |
| 2026-03-20 | FMS | 21.65 | 18.9 | -120.4 | 2.55 |
| 2026-03-23 | FMS | 21.89 | 18.9 | -95.2 | 2.55 |
| 2026-03-24 | FMS | 22.03 | 18.9 | -102.4 | 2.55 |
| 2026-03-25 | FMS | 22.28 | 18.9 | -102.8 | 2.55 |
| 2026-03-26 | FMS | 22.36 | 18.9 | -111.6 | 2.55 |
| 2026-03-27 | FMS | 22.07 | 18.9 | -130.9 | 2.55 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
20 items
«
‹
Current Page1 of 1
›
»
20 items
«
‹
of 1
›
»
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2026-02-27 | FMS | 0.00 | 0.13 | 0.32 |
| 2026-03-02 | FMS | 0.00 | -0.31 | 0.33 |
| 2026-03-03 | FMS | 0.00 | -0.31 | 0.33 |
| 2026-03-04 | FMS | 0.00 | -0.31 | 0.33 |
| 2026-03-05 | FMS | 0.00 | -0.31 | 0.33 |
| 2026-03-06 | FMS | 0.00 | -0.31 | 0.33 |
| 2026-03-09 | FMS | 0.00 | -0.39 | 0.33 |
| 2026-03-10 | FMS | 0.00 | -0.39 | 0.33 |
| 2026-03-11 | FMS | 0.00 | -0.39 | 0.37 |
| 2026-03-12 | FMS | 0.00 | -0.39 | 0.37 |
| 2026-03-13 | FMS | 0.00 | -0.39 | 0.37 |
| 2026-03-17 | FMS | 0.00 | -0.37 | 0.37 |
| 2026-03-18 | FMS | 0.00 | -0.37 | 0.37 |
| 2026-03-19 | FMS | 0.00 | -0.37 | 0.37 |
| 2026-03-20 | FMS | 0.00 | -0.37 | 0.37 |
| 2026-03-23 | FMS | 0.00 | -0.35 | 0.37 |
| 2026-03-24 | FMS | 0.00 | -0.35 | 0.37 |
| 2026-03-25 | FMS | 0.00 | -0.35 | 0.33 |
| 2026-03-26 | FMS | 0.00 | -0.35 | 0.33 |
| 2026-03-27 | FMS | 0.00 | -0.35 | 0.33 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
20 items
«
‹
Current Page1 of 1
›
»
Last Quarter Act. EPS
0.83
Avg. EPS Est. Current Quarter
0.5
Avg. EPS Est. Next Quarter
0.52
Insider Transactions
Institutional Transactions
-0.35
Beta
0.87
Average Sales Estimate Current Quarter
4726
Average Sales Estimate Next Quarter
4789
Fair Value
24.17
Quality Score
62
Growth Score
63
Sentiment Score
60
Actual DrawDown %
48
Max Drawdown 5-Year %
-68.8
Target Price
25.59
P/E
11.48
Forward P/E
8.53
PEG
1.69
P/S
0.56
P/B
0.79
P/Free Cash Flow
6.16
EPS
1.92
Average EPS Est. Cur. Y
2.55
EPS Next Y. (Est.)
3.48
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
5.03
Relative Volume
0.45
Return on Equity vs Sector %
-20
Return on Equity vs Industry %
-125.8
EPS 1 7Days Diff
EPS 1 30Days Diff
-0.37
EBIT Estimation
-130.9
◆
FMS
Healthcare
$22.06
📉
N/A
Swing / Pullback
Buy the dip on strong trends
WEAK
Trend
0/20
Pullback
17/25
Volume
11/15
Valuation
16/20
TP/AR
0/10
Options
2/10
RSI
40.9
Range 1M
40.5%
Sup Dist
0%
🚀
N/A
Momentum Growth
Ride accelerating trends
WEAK
Momentum
0/25
Growth
11/30
Estimates
4/20
Inst/Vol
0/15
Options
3/10
EPS Yr
-5.5%
EPS NY
8.7%
52W%
15%
💎
N/A
Long-Term Value
Quality companies, undervalued
WEAK
🟢 BUY
+129.6% upside
Quality
6/30
Valuation
20/30
Growth
9/25
Stability
3/10
LT Trend
1/5
Upside
+129.6%
Quality
62
MoS
10%
Click a card to see score breakdown
Full Analysis →
Sector: Healthcare
Industry: Medical Care Facilities
Employees: 109698
Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, the United States, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. The company operates through Care Delivery and Care Enablement segments. It also develops, manufactures, and distributes various health care products, including hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, systems for water treatment, and acute cardiopulmonary and apheresis products. In addition, the company develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular specialty, ambulatory surgery center, physician nephrology practice management, pharmacy and other services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics, as well as through local sales forces, independent distributors, dealers, and sales agents. The company was incorporated in 1996 and is headquartered in Bad Homburg, Germany.
FMS
Latest News
—
Caricamento notizie per FMS…
stock quote shares FMS – Fresenius Medical Care AG ADR Stock Price stock today
news today FMS – Fresenius Medical Care AG ADR stock forecast ,stock prediction 2023 2024 2025
marketwatch FMS – Fresenius Medical Care AG ADR yahoo finance google finance
stock history FMS – Fresenius Medical Care AG ADR invest stock market
stock prices FMS premarket after hours
ticker FMS fair value insiders trading